Inhibition of Tungsten-Induced Protein Aggregation by Cetyl Trimethyl Ammonium Bromide

References

1. 1.↵
   1. Swift R.,
   2. Nashed-Samuel Y.,
   3. Liu W.,
   4. Narhi L.,
   5. Davis J.

   Tungsten, Prefilled Syringes and Protein Aggregation. ACS Meeting, Boston, MA (BIOT 15), 2007.
2. 2.↵
   1. Bee J. S.,
   2. Nelson S. A.,
   3. Freund E.,
   4. Carpenter J. F.,
   5. Randolph T. W.

   Precipitation of a monoclonal antibody by soluble tungsten. J. Pharm. Sci. 2009, 98 (9), 3290–3301.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Jiang Y.,
   2. Nashed-Samuel Y.,
   3. Li C.,
   4. Liu W.,
   5. Pollastrini J.,
   6. Mallard D.,
   7. Wen Z. Q.,
   8. Fujimori K.,
   9. Pallitto M.,
   10. Donahue L.,
   11. Chu G.,
   12. Torraca G.,
   13. Vance A.,
   14. Mire-Sluis T.,
   15. Freund E.,
   16. Davis J.,
   17. Narhi L.

   Tungsten-induced protein aggregation: solution behavior. J. Pharm. Sci. 2009, 98 (12), 4695–4710.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Liu W.,
   2. Swift R.,
   3. Torraca G.,
   4. Nashed-Samuel Y.,
   5. Wen Z.,
   6. Jiang Y.,
   7. Vance A.,
   8. Mire-Sluis A.,
   9. Freund E.,
   10. Davis J.,
   11. Narhi L. O.

   Root cause analysis of tungsten induced protein aggregation in pre-filled syringes. PDA J. Pharm. Sci. Technol. 2010, 64 (1), 11–19.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Lassner E.,
   2. Schubert W.-D.

   Tungsten: Properties, Chemistry, Technology of the Element, Alloys, and Chemical Compounds, 1st ed.; Kluwer Academic/Plenum Publishers: New York, 1999.
6. 6.↵
   1. Serno T.,
   2. Carpenter J. F.,
   3. Randolph T. W.,
   4. Winter G.

   Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-β-cyclodextrin. J. Pharm. Sci. 2010, 99 (3), 1193–1206.

   OpenUrlPubMed
7. 7.↵
   1. Smith B. J.,
   2. Patrick V. A.

   Quantitative determination of sodium metatungstate speciation by 183W N.M.R. spectroscopy. Australian Journal of Chemistry 2000, 53 (12), 965–970.

   OpenUrl
8. 8.↵
   1. Mahler H.-C.,
   2. Freiss W.,
   3. Grauschopf U.,
   4. Keise S.

   Protein aggregation: pathways, induction factors and analysis. J. Pharm. Sci. 2009, 98 (9), 2909–2934.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Philo J. S.

   Is any measurement method optimal for all aggregate sizes and types? AAPS J. 2006, 8 (3), E564–E571.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Philo J. S.

    A critical review of methods for size characterization of non-particulate protein aggregates. Curr. Pharm. Biotechnol. 2009, 10 (4), 359–372.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Singh S. K.,
    2. Afonina N.,
    3. Awwad M.,
    4. Bechtold-Peters K.,
    5. Blue J.,
    6. Chou D.,
    7. Cromwell M.,
    8. Krause H. J.,
    9. Mahler H.-C.,
    10. Meyer B.,
    11. Narhi L.,
    12. Nesta D.,
    13. Spitznagel T.

    An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. J. Pharm. Sci. 2010, 99 (8), 3302–3321.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Rosenberg A. S.

    Effect of protein aggregates: an immunologic perspective. AAPS J. 2006, 8 (3), E501–E507.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Carpenter J. F.,
    2. Randolph T. W.,
    3. Jiskoot W.,
    4. Crommelin D. J.,
    5. Middaugh C. R.,
    6. Winter G.,
    7. Fan Y. X.,
    8. Kirshner S.,
    9. Verthelyi D.,
    10. Kozlowski S.,
    11. Clouse K. A.,
    12. Swann P. G.,
    13. Rosenberg A.,
    14. Cherney B.

    Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. J. Pharm. Sci. 2009, 98 (4), 1201–1205.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Chen L.,
    2. Zhang D.,
    3. Chen J.,
    4. Zhou H.,
    5. Wan H.

    The use of CTAB to control the size of copper nanoparticles and the concentration of alkylthiols on their surfaces. Materials Science and Engineering, A 2006, 414 (1–2), 156–161.

    OpenUrl
15. 15.↵
    1. Reynolds J. E. F.

    , Ed. Martindale: The Extra Pharmacopoeia, 30th ed.; Pharmaceutical Press: London, 1994.
16. 16.↵
    1. Singh M.,
    2. Briones M.,
    3. Ott G.,
    4. O'Hagan D.

    Cationic microparticles: a potent delivery system for DNA vaccines. Proc. Natl. Acad. Sci. U S A 2000, 97 (2), 811–816.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Krejcarek G.,
    2. Tucker K.

    Covalent attachment of chelating groups to macromolecules. Biochem. Biophys. Res. Commun. 1977, 77 (2), 518–585.

    OpenUrlPubMed
18. 18.↵
    1. Ligeti M.,
    2. Gunduz O.,
    3. Magyar A.,
    4. Kata E.,
    5. Ronai A.,
    6. Via C.,
    7. Varga I.,
    8. Hudecz F.,
    9. Toth G.,
    10. Borsodi A.,
    11. Benyhe S.

    Synthesis and biological studies of nociceptin derivatives containing the DTPA chelating group for further labeling with therapeutic radionuclides. Peptides 2005, 26 (7), 1159–1166.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Huang C. T.,
    2. Sharma D.,
    3. Oma P.,
    4. Krishnamurthy R.

    Quantitation of protein particles in parenteral solutions using micro-flow imaging. J. Pharm. Sci. 2008, 98 (9), 3058–3071.

    OpenUrl
20. 20.↵
    1. Wuchner K.,
    2. Büchler J.,
    3. Spycher R.,
    4. Dalmonte P.,
    5. Volkin D. B.

    Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody. J. Pharm. Sci. 2010, 99 (8), 3343–3361.

    OpenUrlPubMed
21. 21.↵
    1. Sharma D. K.,
    2. Oma P.,
    3. Pollo M. J.,
    4. Sukumar M.

    Quantification and characterization of subvisible proteinaceous particles in opalscent mAb formulations using micro-flow imaging. J. Pharm. Sci. 2010, 99 (6), 2628–2642.

    OpenUrlPubMed
22. 22.↵
    1. Carpenter J. F.,
    2. Randolph T. W.,
    3. Jiskoot W.,
    4. Crommelin D. J.,
    5. Middaugh C. R.,
    6. Winter G.

    Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products. J. Pharm. Sci. 2010, 99 (5), 2200–2208.

    OpenUrlPubMed
23. 23.↵
    1. Morrison I. D.,
    2. Ross S.

    Colloidal Dispersions: Suspensions, Emulsions, and Foams; Wiley-Interscience: New York, 2002.
24. 24.↵
    1. Shaw D. J.

    Introduction to Colloid and Surface Chemistry, 4th ed.; Butterworth-Heinemann: Oxford, 1992.
25. 25.↵
    1. Gregory J.

    Particles in Water: Properties and Processes; Taylor and Francis: New York, 2006.